Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial

Tenna Bloch Frandsen, Manan Pareek, Jens Peter Hansen, Connie Thuroee Nielsen, Tenna Bloch Frandsen, Manan Pareek, Jens Peter Hansen, Connie Thuroee Nielsen

Abstract

Background: Low serum 25-hydroxyvitamin D levels (25(OH)D) have been associated with a higher likelihood of seasonal affective disorder (SAD) and poor mental well-being, yet firm evidence for either remains lacking. Thus, vitamin D supplementation may alleviate symptoms associated with SAD.

Methods: This study was a randomized, single-centre, double-blind, placebo-controlled trial including healthcare professionals employed in psychiatric and somatic hospitals. 3345 healthcare professionals were invited to participate, 50 participants were screened, and 34 were able to complete the study. The main inclusion criterion was 8 points or more on question no. 2 of the Seasonal Pattern Assessment Questionnaire (SPAQ-SAD). During a 3-month period, the participants received a daily dose of 70 μg vitamin D or placebo. The primary outcome was the sum of the self-reported questionnaire Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders (SIGH-SAD). The secondary outcome was World Health Organization-Five Well-Being Index (WHO-5) of the healthcare professionals during the winter period and the exploratory outcome measures were weight, waist circumference, blood pressure, absenteeism from work and 25(OH)D.

Results: There were no significant between-group differences in SIGH-SAD sums at 12 weeks (p = 0.7 (CI: - 3.27 to 4.81)). However, there was a significant improvement of primary SIGH-SAD over time from inclusion (autumn-winter) to the completion of the study (winter-spring) for all participants. The secondary and exploratory outcome measures were all insignificant between groups.The sums of the SIGH-SAD at 12 weeks were not significantly different [p = 0.701 (CI: 4.81-3.27)] between the groups. There was, however, a significant improvement in primary SIGH-SAD sums over time from inclusion (autumn-winter) to the completion of the study (winter-spring) in both groups. The secondary and explorative outcome measures were not significantly different between groups.

Conclusions: There were no significant between-group differences in the primary (SIGH-SAD) and secondary (WH0-5) as well as the exploratory outcome measures (weight, waist circumference, blood pressure, absenteeism from work and 25(OH)D. Thus, the study failed to demonstrate an effect of vitamin D on SAD symptoms, but our findings may be limited by confounders. Furthermore, the study was underpowered and did not allow us to assess the ability of vitamin D to improve mood in those with low 25(OH)D.

Trial registration: ( http://www.clinicaltrials.gov registration number: NCT01462058).

Figures

Figure 1
Figure 1
Flow of participants.
Figure 2
Figure 2
Depression symptoms on SIGH-SAD.

References

    1. Hansen V, Skre I, Lund E. What is this thing called "SAD"? A critique of the concept of Seasonal Affective Disorder. Epidemiologia e psichiatria sociale. 2008;17(2):120–127.
    1. Madsen HO, Dam H, Hageman I. [Seasonal affective disorder] UgeskrLaeger. 2011;173(47):3013–3016.
    1. Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a neuroactive substance: review. Sci World J. 2006;6:125–139. doi: 10.1100/tsw.2006.25.
    1. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30. doi: 10.1016/j.jchemneu.2004.08.006.
    1. Rucker D, Allan JA, Fick GH, Hanley DA. Vitamin D insufficiency in a population of healthy western Canadians. Can Med Assoc J. 2002;166(12):1517–1524.
    1. Mosekilde L, Nielsen LR, Larsen ER, Moosgaard B, Heickendorff L. [Vitamin D deficiency. Definition and prevalence in Denmark] UgeskrLaeger. 2005;167(1):29–33.
    1. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–871. doi: 10.1001/archderm.1988.01670060015008.
    1. Godar DE, Pope SJ, Grant WB, Holick MF. Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol. Dermatoendocrinol. 2011;3(4):243–250. doi: 10.4161/derm.3.4.15292.
    1. Shipowick CD, Moore CB, Corbett C, Bindler R. Vitamin D and depressive symptoms in women during the winter: a pilot study. Appl Nurs Res. 2009;22(3):221–225. doi: 10.1016/j.apnr.2007.08.001.
    1. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8. doi: 10.1186/1475-2891-3-8.
    1. Gloth FM, 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5–7.
    1. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008;264(6):599–609. doi: 10.1111/j.1365-2796.2008.02008.x.
    1. Dumville JC, Miles JN, Porthouse J, Cockayne S, Saxon L, King C. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging. 2006;10(2):151–153.
    1. Harris S, Dawson-Hughes B. Seasonal mood changes in 250 normal women. Psychiatry Res. 1993;49(1):77–87. doi: 10.1016/0165-1781(93)90031-B.
    1. Hahn IH, Grynderup MB, Dalsgaard SB, Thomsen JF, Hansen AM, Kaergaard A, Kærlev L, Mors O, Rugulies R, Mikkelsen S, Bonde JP, Kolstad HA. Does outdoor work during the winter season protect against depression and mood difficulties? Scand J Work Environ Health. 2011;37(5):446–449. doi: 10.5271/sjweh.3155.
    1. Schweizer C, Edwards RD, Bayer-Oglesby L, Gauderman WJ, Ilacqua V, Jantunen MJ, Lai HK, Nieuwenhuijsen M, Künzli N. Indoor time-microenvironment-activity patterns in seven regions of Europe. J Expo Sci Environ Epidemiol. 2007;17(2):170–181. doi: 10.1038/sj.jes.7500490.
    1. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–662. doi: 10.1176/appi.ajp.162.4.656.
    1. Partonen T, Vakkuri O, Lamberg-Allardt C, Lonnqvist J. Effects of bright light on sleepiness, melatonin, and 25-hydroxyvitamin D(3) in winter seasonal affective disorder. Biol Psychiatry. 1996;39(10):865–872. doi: 10.1016/0006-3223(95)00294-4.
    1. Michalak EE, Murray G, Wilkinson C, Dowrick C, Lam RW. A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Res. 2007;149(1–3):315–320. doi: 10.1016/j.psychres.2006.05.005.
    1. Roecklein KA, Schumacher JA, Miller MA, Ernecoff NC. Cognitive and behavioral predictors of light therapy use. PLoS One. 2012;7(6):e39275. doi: 10.1371/journal.pone.0039275.
    1. Thaler K, Delivuk M, Chapman A, Gaynes BN, Kaminski A, Gartlehner G: Second-generation antidepressants for seasonal affective disorder.Cochrane Database Syst Rev 2011.,2011(12): CD008591
    1. Kasper S, Wehr TA, Bartko JJ, Gaist PA, Rosenthal NE. Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry. 1989;46(9):823–833. doi: 10.1001/archpsyc.1989.01810090065010.
    1. Rosenthal NE Brath GH, Wehr TA. Seasonal Pattern Assesment Questionnaire; National Institute of Mental Health. 1987.
    1. Magnusson A. An overview of epidemiological studies on seasonal affective disorder. Acta Psychiatr Scand. 2000;101(3):176–184. doi: 10.1034/j.1600-0447.2000.101003176.x.
    1. Williams J, Link M, Rosenthal N. Structured Interview Guide for the Hamilton Depression Raing Scale - Seasonal Affective Disorder Version (SIGH-SAD) New York: New York: State Psychiatric Institute; 1992.
    1. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: A comparison of the SF-36 Mental Health subscale and the WHO-FiveWell-Being Scale. Int J Methods Psychiatr Res. 2003;12:85–91. doi: 10.1002/mpr.145.
    1. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296. doi: 10.1111/j.2044-8260.1967.tb00530.x.
    1. Mersch PP, Vastenburg NC, Meesters Y, Bouhuys AL, Beersma DG, van den Hoofdakker RH, den Boer JA. The reliability and validity of the seasonal pattern assessment questionnaire: a comparison between patient groups. J Affect Disord. 2004;80(2–3):209–219. doi: 10.1016/S0165-0327(03)00114-9.
    1. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. 2008;159(6):675–684. doi: 10.1530/EJE-08-0339.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi